Eton Pharmaceuticals Files 2024 10-K
Ticker: ETON · Form: 10-K · Filed: Mar 18, 2025 · CIK: 1710340
| Field | Detail |
|---|---|
| Company | Eton Pharmaceuticals, Inc. (ETON) |
| Form Type | 10-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-k, financials, pharmaceuticals
TL;DR
Eton Pharma's 2024 10-K shows $26.7M assets, $25.7M liabilities. Worth a look.
AI Summary
Eton Pharmaceuticals, Inc. filed its 2024 10-K on March 18, 2025, reporting its fiscal year ended December 31, 2024. The company's financial statements indicate total assets of $26,709,084 and total liabilities of $25,688,062. Eton Pharmaceuticals, Inc. is incorporated in Delaware and operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides a comprehensive overview of Eton Pharmaceuticals' financial health and operational status for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — The company has significantly more liabilities than assets, indicating potential financial strain.
Key Numbers
- $26.7B — Total Assets (As of December 31, 2024)
- $25.7B — Total Liabilities (As of December 31, 2024)
- 50,000,000 — Authorized Shares (Common stock authorized)
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-18 (date) — Filing date
- DE (state) — State of incorporation
- $26,709,084 (dollar_amount) — Total assets
- $25,688,062 (dollar_amount) — Total liabilities
FAQ
What was the net income or loss for Eton Pharmaceuticals for the fiscal year ended December 31, 2024?
The provided snippet does not contain specific net income or loss figures for the fiscal year ended December 31, 2024.
What is the company's revenue for the fiscal year ended December 31, 2024?
The provided snippet does not contain revenue figures for the fiscal year ended December 31, 2024.
What is the company's cash and cash equivalents balance as of December 31, 2024?
The provided snippet does not explicitly state the cash and cash equivalents balance.
What were the total operating expenses for the fiscal year ended December 31, 2024?
The provided snippet does not detail total operating expenses for the fiscal year ended December 31, 2024.
What is the company's debt structure or outstanding debt as of December 31, 2024?
The provided snippet does not contain information regarding the company's debt structure or outstanding debt.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 18, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).